ORCID
- Jeremy Hobart: 0000-0002-2114-7920
DOI Link
Publication Date
2022-01-01
Publication Title
Multiple Sclerosis and Related Disorders
Volume
63
ISSN
2211-0348
Acceptance Date
2022-05-16
Deposit Date
2022-01-07
Embargo Period
2022-07-02
Recommended Citation
Dobson, R., Craner, M., Waddingham, E., Miller, A., Pindoria, J., Cavey, A., Blain, C., De, L., Evangelou, N., Ford, H., Gallagher, P., George, K., Geraldes, R., Harman, P., Hobart, J., King, T., Linighan, R., MacDougall, N., Marta, M., Mitchell, S., Nicholas, R., Rog, D., Scalfari, A., Scolding, N., Webb, S., White, S., Wilton, J., Young, C., & Matthews, P. (2022) 'Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)', Multiple Sclerosis and Related Disorders, 63. Available at: 10.1016/j.msard.2022.103894
